|
Volumn 6, Issue 12, 2000, Pages 4658-4662
|
Vaccination with a bivalent GM2 and GD2 ganglioside conjugate vaccine: A trial comparing doses of GD2-keyhole limpet hemocyanin
a b a a a b b a |
Author keywords
[No Author keywords available]
|
Indexed keywords
GANGLIOSIDE GD2;
GANGLIOSIDE GM2;
IMMUNOGLOBULIN G ANTIBODY;
IMMUNOGLOBULIN M ANTIBODY;
KEYHOLE LIMPET HEMOCYANIN;
ANTIBODY RESPONSE;
ARTICLE;
CANCER IMMUNIZATION;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG SAFETY;
FEMALE;
HUMAN;
IMMUNOGENICITY;
MALE;
MELANOMA;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SARCOMA;
CANCER VACCINES;
CHROMATOGRAPHY, THIN LAYER;
DOSE-RESPONSE RELATIONSHIP, DRUG;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
FEMALE;
FLOW CYTOMETRY;
G(M2) GANGLIOSIDE;
GANGLIOSIDES;
HEMOCYANIN;
HUMANS;
IMMUNOBLOTTING;
IMMUNOGLOBULIN G;
IMMUNOGLOBULIN M;
MALE;
MELANOMA;
RECURRENCE;
SARCOMA;
TIME FACTORS;
|
EID: 0034490177
PISSN: 10780432
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (56)
|
References (17)
|